OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price objective among analysts […]
Shares of Asure Software, Inc. (NASDAQ:ASUR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price […]
Shares of Asure Software, Inc. (NASDAQ:ASUR – Get Free Report) have received an average recommendation of “Moderate Buy” from the eight research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and six have assigned a buy rating […]
Avenir Corp cut its holdings in OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 7.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 381,660 shares of the company’s stock after selling 32,913 shares during the quarter. OptimizeRx makes up 0.5% of Avenir Corp’s holdings, […]
Symbotic (NASDAQ:SYM – Free Report) had its target price lifted by KeyCorp from $50.00 to $63.00 in a research report sent to investors on Tuesday, Benzinga reports. KeyCorp currently has an overweight rating on the stock. KeyCorp also issued estimates for Symbotic’s Q1 2024 earnings at ($0.04) EPS, Q2 2024 earnings at $0.01 EPS, Q4 […]